Nasopharyngeal Carcinoma (NPC): The Influence of Different Types of Interferon (IFN) on Peripheral Blood Lymphocytes
G. Bertram, G. R. F. Krueger
Abstract
G. Bertram, G. R. F. Krueger
Abstract
About 2/3 of all patients with nasopharyngeal carcinoma (NPC) have tumor recurrences within the first 3 years after diagnosis and primary radiotherapy. Adjuvant chemotherapy showed neither improvement of prognosis nor prolongation of the relapse-free intervall as compared to radiotherapy alone. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
About 2/3 of all patients with nasopharyngeal carcinoma (NPC) have tumor recurrences within the first 3 years after diagnosis and primary radiotherapy. Adjuvant chemotherapy showed neither improvement of prognosis nor prolongation of the relapse-free intervall as compared to radiotherapy alone. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Key concepts: Nasopharyngeal carcinoma, Medicine, Peripheral blood, Radiation therapy, Oncology, Internal medicine, Chemotherapy, Adjuvant